Star Combo Pharma Limited announced group revenue results for the second quarter ended 31 December 2021. The group revenue was $6.0 million for the second quarter ended 31 December 2021, compared with $7.5 million for the same period a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 AUD | -8.33% | -8.33% | -24.14% |
02-27 | Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
2023 | Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-24.14% | 9.78M | |
-.--% | 843M | |
+5.51% | 710M | |
+30.38% | 475M | |
+22.65% | 238M | |
0.00% | 162M | |
+113.04% | 59.36M |
- Stock Market
- Equities
- S66 Stock
- News Star Combo Pharma Limited
- Star Combo Pharma Limited Announces Group Revenue Results for the Second Quarter Ended 31 December 2021